The actinobacterium Streptomyces wadayamensis A23 is an endophyte of Citrus reticulata that produces the antimycin and mannopeptimycin antibiotics, among others. The strain has the capability to inhibit Xylella fastidiosa growth. The draft genome of S. wadayamensis A23 has~7.0 Mb and 6,006 protein-coding sequences, with a 73.5% G؉C content. 
treptomyces wadayamensis strain A23 is an actinobacterium isolated from the population existing in the plant tissue of Citrus reticulata (tangerine) (1) . The isolate shows a high capability to promote in vitro inhibition of Xylella fastidiosa growth, as well as to promote the degradation of xanthan gum. Additionally, ethyl acetate extracts from S. wadayamensis fermentation were able to inhibit the Candida albicans pathogen, Neisseria meningitidis strains, and multiresistant Staphylococcus aureus (L. G. de Oliveira, P. L. R. Cruz, A. B. Gonçalves, M. Samborsky, A. F. Vivian, E. M. Schmidt, M. N. Eberlin, and W. L. Araújo, unpublished data).
The draft genome sequence of S. wadayamensis was generated using Illumina MiSeq technology at the Department of Biochemistry, University of Cambridge, Cambridge, England, supported by the São Paulo Funding Agency. The libraries of the S. wadayamensis strain were prepared using the Nextera library prep kit, sequenced using V2 Illumina sequencing chemistry, and run on MiSeq (2 ϫ 150 bp paired-end [PE] sequencing). The Illumina shotgun library produced 7.8 million reads in a total of 2.4 Gb data. After filtering and adapter and quality trimming, the sequencing results were assembled using the Lasergene SeqMan NGen version 3.1 (DNAStar) assembler program, providing 96ϫ total genome coverage. The assembly was converted to Consedcompatible ace format and checked using Consed (2, 3), generating 180 contigs. Annotation was carried out using a customized pipeline based on FgeneSB, operating in the ab initio mode. The annotation results were edited using Artemis (4). RAST server annotation (5) allowed the identification of 6,006 candidate protein-coding genes. Additionally, 17 transcription factor initiators and subsystems related to the biosynthesis of secondary metabolites, fatty acids, lipids, isoprenoids, and siderophores, such as desferrioxamine and aerobactin, were identified. The total genome size comprises 7,056,544 bp, with a GϩC content of 73.5%.
It is widely known that members of the Streptomyces genus carry a very versatile group of biosynthetic machineries capable of producing complex molecules that present antibiotic, antitumor, and immunosuppressant activities. Careful analysis of the genome annotation revealed a great ability to biosynthesize antibiotic metabolites. Further analysis through antiSMASH (6) revealed that the S. wadayamensis A23 genome contains at least 36 gene clusters coding for the biosynthesis of t1-polyketide synthase (PKS), t2-PKS, and t3-PKS, nonribosomal peptide synthase (NRPS), terpene, lantipeptide, siderophore, bacteriocin, and ectoine and NRPS-t1-PKS, lantipeptide-NRPS-t1-PKS, tiopeptide-lantipeptide, and bacteriocin-terpene mixed clusters. Siderophores, such as aerobactin, enterobactin, and desferrioxamine B and E, nonribosomal peptides, such as mannopeptimycin, and NRPS-PKS antimycins A1, A4, A7, and A8 are among the metabolites already identified from culture extracts.
Though no xanthanases or xanthan degradation-specific enzymes were suggested in the genome annotation, several enzymes involved in mannose metabolism, alpha-and beta-glucosidases, and secreted endoglucanases were annotated, suggesting that fastidian gum might be degraded by this set of enzymes, and anticipating that S. wadayamensis might assist in the control of X. fastidiosa pathogenicity in C. reticulata.
Nucleotide sequence accession numbers. This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. JHDU00000000. The version described in this paper is the first version, JHDU01000000.
